Tenax completes enrolment for Phase III cardiac surgery trial of levosimendan

US-based specialty pharmaceutical company Tenax has completed patient enrolment in its Phase III LEVO-CTS trial of Levosimendan to be used during cardiac surgery.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals